natgillin/translations-raw huggingface dataset:
Member States shall adopt and publish by 31 October 2009 at the latest the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 31. oktobra 2009.
Member States shall in accordance with Directive 91/414/EEC, where necessary, amend or withdraw existing authorisations for plant protection products containing abamectin, epoxiconazole, fenpropimorph, fenpyroximate and tralkoxydim as active substances by 31 October 2009.
Države članice v skladu z Direktivo 91/414/EGS do 31. oktobra 2009 po potrebi spremenijo ali prekličejo obstoječe registracije fitofarmacevtskih sredstev, ki vsebujejo abamektin, epoksikonazol, fenpropimorf, fenpiroksimat in tralkoksidim kot aktivne snovi.
By that date they shall in particular verify that the conditions in Annex I to that Directive relating to abamectin, epoxiconazole, fenpropimorph, fenpyroximate and tralkoxydim are met, with the exception of those identified in part B of the entry concerning that active substance, and that the holder of the authorisation has, or has access to, a dossier satisfying the requirements of Annex II to that Directive in accordance with the conditions of Article 13 of that Directive.
Do navedenega datuma zlasti preverijo, ali so pogoji iz Priloge I k navedeni direktivi v zvezi z abamektinom, epoksikonazolom, fenpropimorfom, fenpiroksimatom in tralkoksidimom, z izjemo tistih iz dela B besedila o navedeni aktivni snovi, izpolnjeni in ali ima imetnik registracije dokumentacijo ali dostop do dokumentacije, ki izpolnjuje zahteve iz Priloge II k navedeni direktivi v skladu s pogoji iz člena 13 navedene direktive.
By way of derogation from paragraph 1, for each authorised plant protection product containing abamectin, epoxiconazole, fenpropimorph, fenpyroximate and tralkoxydim as either the only active substance or as one of several active substances all of which were listed in Annex I to Directive 91/414/EEC by 30 April 2009 at the latest, Member States shall re-evaluate the product in accordance with the uniform principles provided for in Annex VI to Directive 91/414/EEC, on the basis of a dossier satisfying the requirements of Annex III to that Directive and taking into account part B of the entry in Annex I to that Directive concerning abamectin, epoxiconazole, fenpropimorph, fenpyroximate and tralkoxydim respectively.
Z odstopanjem od odstavka 1 države članice znova ocenijo vsako registrirano fitofarmacevtsko sredstvo, ki vsebuje abamektin, epoksikonazol, fenpropimorf, fenpiroksimat in tralkoksidim kot edino aktivno snov ali kot eno od aktivnih snovi, vključenih v Prilogo I k Direktivi 91/414/EGS najpozneje do 30. aprila 2009, v skladu z enotnimi načeli iz Priloge VI k Direktivi 91/414/EGS na podlagi dokumentacije, ki izpolnjuje zahteve iz Priloge III k navedeni direktivi, in ob upoštevanju dela B besedila o abamektinu, epoksikonazolu, fenpropimorfu, fenpiroksimatu in tralkoksidimu iz Priloge I k navedeni direktivi.
in the case of a product containing abamectin, epoxiconazole, fenpropimorph, fenpyroximate and tralkoxydim as the only active substance, where necessary, amend or withdraw the authorisation by 30 April 2013 at the latest; or
če sredstvo vsebuje abamektin, epoksikonazol, fenpropimorf, fenpiroksimat in tralkoksidim kot edino aktivno snov, najpozneje do 30. aprila 2013 po potrebi spremenijo ali prekličejo registracijo ali
in the case of a product containing abamectin, epoxiconazole, fenpropimorph, fenpyroximate and tralkoxydim as one of several active substances, where necessary, amend or withdraw the authorisation by 30 April 2013 or by the date fixed for such an amendment or withdrawal in the respective Directive or Directives which added the relevant substance or substances to Annex I to Directive 91/414/EEC, whichever is the latest.
če sredstvo vsebuje abamektin, epoksikonazol, fenpropimorf, fenpiroksimat in tralkoksidim kot eno izmed več aktivnih snovi, registracijo po potrebi spremenijo ali prekličejo do najpozneje 30. aprila 2013 ali do datuma, določenega za takšno spremembo ali preklic v ustreznih direktivah, s katerimi so bile zadevne snovi dodane v Prilogo I k Direktivi 91/414/EGS, pri čemer se upošteva poznejši datum.
This Directive shall enter into force on 1 May 2009.
Ta direktiva začne veljati 1. maja 2009.
Done at Brussels, 25 November 2008.
V Bruslju, 25. novembra 2008
Conclusion regarding the peer review of the pesticide risk assessment of the active substance abamectin (finalised 29 May 2008).EFSA Scientific Report (2008) 138.
Sklep o strokovnem pregledu ocene tveganja pesticidov z aktivno snovjo abamektin (dokončano: 29. maja 2008).Znanstveno poročilo EFSA (2008) 138.
Conclusion regarding the peer review of the pesticide risk assessment of the active substance epoxiconazole (finalised 26 March 2008).EFSA Scientific Report (2008) 144.
Sklep o strokovnem pregledu ocene tveganja pesticidov z aktivno snovjo epoksikonazol (dokončano: 26. marca 2008).Znanstveno poročilo EFSA (2008) 144.
Conclusion regarding the peer review of the pesticide risk assessment of the active substance fenpropimorph (finalised 14 April 2008).EFSA Scientific Report (2008) 143, Conclusion regarding the peer review of the pesticide risk assessment of the active substance fenpyroximate (finalised 5 May 2008).EFSA Scientific Report (2008), Conclusion regarding the peer review of the pesticide risk assessment of the active substance tralkoxydim (finalised 26 March 2008).
Sklep o strokovnem pregledu ocene tveganja pesticidov z aktivno snovjo fenpropimorf (dokončano: 14. aprila 2008).Znanstveno poročilo EFSA (2008) 143. Sklep o strokovnem pregledu ocene tveganja pesticidov z aktivno snovjo fenpiroksimat (dokončano: 5. maja 2008).Znanstveno poročilo EFSA (2008). Sklep o strokovnem pregledu ocene tveganja pesticidov z aktivno snovjo tralkoksidim (dokončano: 26. marca 2008).
CAS No 71751-41-2
Št. CAS 71751-41-2
CAS No 65195-55-3
Št. CAS 65195-55-3
CAS No 65195-56-4
Št. CAS 65195-56-4
CIPAC No 495
Št. CIPAC 495
AvermectinB1a
Avermectin B1a
(10E,14E,16E,22Z)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-6′-[(S)-sec-butyl]-21,24-dihydroxy-5′,11.13,22-tetramethyl-2-oxo-3.7,19-trioxatetracyclo[15.6.1.14,8 020,24]pentacosa-10.14,16,22-tetraene-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-3-O-methyl-α-L-arabino-hexopyranoside
(10E,14E,16E,22Z)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-6′-[(S)-sec-butyl]-21,24-dihydroxy-5′,11,13,22-tetramethyl-2-oxo-3,7,19-trioxatetracyclo[15.6.1.14,8 020,24]pentacosa-10,14,16,22-tetraene-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-3-O-methyl-α-L-arabino-hexopyranoside
(10E,14E,16E,22Z)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-21,24-dihydroxy-6′-isopropyl-5′,11.13,22-tetramethyl-2-oxo-3.7,19-trioxatetracyclo[15.6.1.14,8 020,24]pentacosa-10.14,16,22-tetraene-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-3-O-methyl-α-L-arabino-hexopyranoside
(10E,14E,16E,22Z)-(1R,4S,5′S,6S,6′R,8R,12S,13S,20R,21R,24S)-21,24-dihydroxy-6′-isopropyl-5′,11,13,22-tetramethyl-2-oxo-3,7,19-trioxatetracyclo[15.6.1.14,8 020,24]pentacosa-10,14,16,22-tetraene-6-spiro-2′-(5′,6′-dihydro-2′H-pyran)-12-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-3-O-methyl-α-L-arabino-hexopyranoside
1 May 2009
maj 2009
30 April 2019
april 2019
Only uses as insecticide, acaricide.
Registrira se lahko samo kot insekticid in akaricid.
In assessing applications to authorise plant protection products containing abamectin for uses other than citrus, lettuce and tomatoes, Member States shall pay particular attention to the criteria in Article 4(1)(b), and shall ensure that any necessary data and information are provided before such an authorisation is granted.
Pri ocenjevanju vlog za registracijo fitofarmacevtskih sredstev, ki vsebujejo abamektin, za druge uporabe kot za agrume, solato in paradižnike, so države članice zlasti pozorne na merila iz člena 4(1)(b) in zagotovijo, da se pred odobritvijo takšne registracije predložijo vsi potrebni podatki in informacije.
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on (abamectin), and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 11 July 2008 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za abamektin ter zlasti dodatkov I in II h končni različici poročila, ki jo je Stalni odbor za prehranjevalno verigo in zdravje živali pripravil 11. julija 2008.
the residues in food of plant origin and evaluate the dietary exposure of consumers,
ostanke rastlinskega izvora v živilih ter oceniti izpostavljenost potrošnikov prek živil,
the protection of bees, non-target arthropods, birds, mammals and aquatic organisms.
zaščito čebel, neciljnih členonožcev, ptičev, sesalcev in vodnih organizmov.
In relation to these identified risks risk mitigation measures, such as buffer zones, waiting periods, should be applied where appropriate.
V zvezi s temi opredeljenimi tveganji je treba po potrebi uporabiti ukrepe za zmanjšanje tveganja, kot so čakalne dobe, varovalni pas.
further studies on the specification,
dodatne študije o specifikaciji,
information to further address the risk assessment for birds and mammals,
informacije za nadaljnjo obravnavo ocene tveganja za ptiče in sesalce,
information to address the risk to aquatic organisms with respect to the major soil metabolites,
informacije za nadaljnjo obravnavo tveganja za vodne organizme v zvezi z glavnimi metaboliti v tleh,
information to address the risk to groundwater with respect to the metabolite U8.
informacije za nadaljnjo obravnavo tveganja za podtalnico v zvezi z metabolitom U8.
They shall ensure that the notifiers provide such studies to the Commission within two years from the entry into force of this Directive.
Države članice zagotovijo, da prijavitelji Komisiji predložijo takšne študije v dveh letih od začetka veljavnosti te direktive.
CAS No 135319-73-2 (formerly 106325-08-0)
Št. CAS 135319-73-2 (stara številka 106325-08-0)
CIPAC No 609
Št. CIPAC 609
(2RS, 3SR)-1-[3-(2-chlorophenyl)-2,3-epoxy-2-(4-fluorophenyl)propyl]-1H-1.2,4-triazole
(2RS, 3SR)-1-[3-(2-chlorophenyl)-2,3-epoxy-2-(4-fluorophenyl)propyl]-1H-1,2,4-triazole
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on epoxiconazole, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 11 July 2008 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za epoksikonazol ter zlasti dodatkov I in II h končni različici poročila, ki jo je Stalni odbor za prehranjevalno verigo in zdravje živali pripravil 11. julija 2008.
the operator safety and ensure that conditions of use prescribe the application of adequate personal protective equipment where appropriate,
varnost izvajalcev tretiranja ter zagotovitev, da je v pogojih uporabe predpisana uporaba ustrezne osebne zaščitne opreme, kadar je potrebno,
the dietary exposure of consumers to the epoxiconazole (triazole) metabolites,
izpostavljenost potrošnikov prek metabolitov epoksikonazola (triazola),
the potential for long-range transport via air,
možnost prenosa po zraku na dolge razdalje,
the risk to aquatic organisms, birds and mammals.
tveganje za vodne organizme, ptiče in sesalce.
Conditions of authorisation shall include risk mitigation measures, where appropriate.
Pogoji registracije po potrebi vključujejo ukrepe za zmanjšanje tveganja.
The Member States concerned shall ensure that the notifier submits to the Commission further studies addressing the potential endocrine disrupting properties of epoxiconazole within two years after the adoption of the OECD test guidelines on endocrine disruption or, alternatively, of Community agreed test guidelines.
Zadevne države članice zagotovijo, da prijavitelj Komisiji predloži dodatne študije za nadaljnjo obravnavo potencialnih motenj endokrinega sistema, ki jih povzroča epoksikonazol, v roku dveh let od sprejetja smernic OECD za preizkušanje motenj endokrinega sistema ali smernic za preizkušanje, sprejetih na ravni Skupnosti.
The Member States concerned shall ensure that the notifier presents to the Commission not later than 30 June 2009 a monitoring programme to assess the long-range atmospheric transport of epoxiconazole and related environmental risks.
Zadevne države članice zagotovijo, da prijavitelj Komisiji najkasneje do 30. junija 2009 predstavi program spremljanja, da se oceni prenos epoksikonazola po zraku na dolge razdalje in z njim povezana okoljska tveganja.
The results of this monitoring shall be submitted as a monitoring report to the Commission by 31 December 2011 at the latest.
Rezultati tega spremljanja se predložijo Komisiji v obliki poročila o spremljanju, najkasneje do 31. decembra 2011.
The concerned Member States shall ensure that the notifier submits within two years from the entry into force of this Directive, at the latest, information on residues of epoxiconazole metabolites in primary crops, rotational crops and products of animal origin and information to further address the long-term risk to herbivorous birds and mammals.
Zadevne države članice zagotovijo, da prijavitelj Komisiji najkasneje v dveh letih od začetka veljavnosti te direktive predloži informacije o ostankih metabolitov epoksikonazola v primarnih pridelkih, gojenih rastlinah v kolobarju in proizvodih živalskega izvora ter informacije za nadaljnjo obravnavo dologročnih tveganj za rastlinojede ptiče in sesalce.
CAS No 67564-91-4
Št. CAS 67564-91-4
CIPAC No 427
Št. CIPAC 427
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on fenpropimorph, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 11 July 2008 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za fenpropimorf ter zlasti dodatkov I in II h končni različici poročila, ki jo je Stalni odbor za prehranjevalno verigo in zdravje živali pripravil 11. julija 2008.
Authorised conditions of use must prescribe the application of adequate personal protective equipment and risk mitigation measures to reduce the exposure, such as restrictions of the daily work rate,
V registriranih pogojih uporabe mora biti predpisana uporaba ustrezne osebne zaščitne opreme in ukrepi za zmanjšanje tveganja za izpostavljenost, kot so na primer omejitve dnevnega obsega dela,
the protection of the groundwater, when the active substance is applied in regions with vulnerable soil and/or climatic conditions,
zaščito podtalnice, kadar se aktivna snov uporablja na območjih z občutljivimi tlemi in/ali podnebnimi razmerami,
Conditions of authorisation should include risk mitigation measures, where appropriate, such as buffer zones, reduction of run-off and drift reduction nozzles.
Pogoji registracije morajo po potrebi vključevati ukrepe za zmanjšanje tveganja, npr. varovalne pasove, zmanjševanje odtekanja ter šobe za preprečevanje zanašanja škropiva.
The Member States concerned shall request the submission of further studies to confirm the mobility in soil of the metabolite BF-421-7.
Zadevne države članice zahtevajo predložitev nadaljnjih študij za potrditev mobilnosti v tleh za metabolit BF-421-7.
They shall ensure that the notifiers at whose request fenpropimorph has been included in this Annex provide such studies to the Commission within two years from the entry into force of this Directive.
Zagotovijo, da prijavitelji, na zahtevo katerih se je fenpropimorf vključil v to prilogo, Komisiji v dveh letih od začetka veljavnosti te direktive predložijo takšne študije.
CAS No 134098-61-6
Št. CAS 134098-61-6
CIPAC No 695
Št. CIPAC 695
applications in high crops with a high risk of spray drift, for example tractor mounted air-blast sprayer and hand-held applications.
uporaba v visokih posevkih z visokim tveganjem zanašanja škropiva, na primer škropilnika na zračni tlak za montažo na traktor in ročnih razpršilnikov.
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on fenpyroximate, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 11 July 2008 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za fenpiroksimat ter zlasti dodatkov I in II h končni različici poročila, ki jo je Stalni odbor za prehranjevalno verigo in zdravje živali pripravil 11. julija 2008.
the impact on aquatic organisms and non-target arthropods and must ensure that the conditions of authorisation include, where appropriate, risk mitigation measures.
vpliv na vodne organizme in neciljne členonožce in morajo zagotoviti, da pogoji registracije po potrebi vključujejo ukrepe za zmanjšanje tveganja.
The Member States concerned shall request the submission of information to further address:
Zadevne države članice zahtevajo predložitev informacij za nadaljnjo obravnavo:
the risk to aquatic organisms from metabolites containing the benzyl moiety,
tveganja, ki ga imajo za vodne organizme metaboliti, ki vsebujejo delež benzila,
the risk of biomagnification in aquatic food chains.
tveganja za biomagnifikacijo v vodni prehranjevalni verigi.
They shall ensure that the notifiers at whose request fenpyroximate has been included in this Annex provide such information to the Commission within two years from the entry into force of this Directive.
Zagotovijo, da prijavitelji, na zahtevo katerih se je fenpiroksimat vključil v to prilogo, Komisiji v dveh letih od začetka veljavnosti te direktive predložijo takšne študije.
CAS No 87820-88-0
Št. CAS 87820-88-0
CIPAC No 544
Št. CIPAC 544
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on tralkoxydim, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 11 July 2008 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za tralkoksidim ter zlasti dodatkov I in II h končni različici poročila, ki jo je Stalni odbor za prehranjevalno verigo in zdravje živali pripravil 11. julija 2008.
the protection of the groundwater, in particular from the soil metabolite R173642 when the active substance is applied in regions with vulnerable soil and/or climatic conditions,
zaščito podtalnice, zlasti pred metabolitom R173642 v tleh, kadar se aktivna snov uporablja na območjih z občutljivimi tlemi in/ali podnebnimi razmerami,
the protection of herbivorous mammals.
zaščito vodnih rastlin.
Conditions of use shall include risk mitigation measures, where appropriate.
Pogoji registracije po potrebi vključujejo ukrepe za zmanjšanje tveganja.
information to further address the long-term risk to herbivorous mammals arising from the use of tralkoxydim.
informacij za nadaljnjo obravnavo dolgoročnega tveganja za rastlinojede sesalce, ki izhaja iz uporabe tralkoksidima.
They shall ensure that the notifiers at whose request tralkoxydim has been included in this Annex provide such information to the Commission within two years from the entry into force of this Directive.’
Zagotovijo, da prijavitelji, na zahtevo katerih se je tralkoksidim vključil v to prilogo, Komisiji v dveh letih od začetka veljavnosti te direktive predložijo takšne študije.“
EFSA Scientific Report (2008) 148.
Znanstveno poročilo EFSA (2008) 148.
Commission Directive 2008/108/EC
Direktiva Komisije 2008/108/ES
amending Council Directive 91/414/EEC to include flutolanil, benfluralin, fluazinam, fuberidazole and mepiquat as active substances
o spremembi Direktive Sveta 91/414/EGS zaradi vključitve flutolanila, benfluralina, fluazinama, fuberidazola in mepikvata kot aktivnih snovi
That list includes flutolanil, benfluralin, fluazinam, fuberidazole and mepiquat.
Na navedenem seznamu so flutolanil, benfluralin, fluazinam, fuberidazol in mepikvat.
For flutolanil the rapporteur Member State was Finland and all relevant information was submitted on 13 June 2005.
Država članica poročevalka za flutolanil je bila Finska, vse ustrezne informacije pa so bile predložene 13. junija 2005.
For benfluralin the rapporteur Member State was Belgium and all relevant information was submitted on 16 February 2006.
Država članica poročevalka za benfluralin je bila Belgija, vse ustrezne informacije pa so bile predložene 16. februarja 2006.
For fluazinam the rapporteur Member State was Austria and all relevant information was submitted on 3 January 2006.
Država članica poročevalka za fluazinam je bila Avstrija, vse ustrezne informacije pa so bile predložene 3. januarja 2006.
For fuberidazole and mepiquat the rapporteur Member State was the United Kingdom and all relevant information was submitted on 5 April 2005.
Država članica poročevalka za fuberidazol in mepikvat je bilo Združeno kraljestvo, vse ustrezne informacije pa so bile predložene 5. aprila 2005.
The assessment reports have been peer reviewed by the Member States and the EFSA and presented to the Commission on 3 March 2008 for flutolanil and benfluralin, on 26 March 2008 for fluazinam, on 14 November 2007 for fuberidazole and on 14 April 2008 for mepiquat in the format of the EFSA Scientific Reports [4].
Poročila o oceni so pregledali strokovnjaki držav članic in EFSA ter jih predstavili Komisiji v obliki znanstvenih poročil EFSA [4], in sicer 3. marca 2008 za flutolanil in benfluralin, 26. marca 2008 za fluazinam, 14. novembra 2007 za fuberidazol ter 14. aprila 2008 za mepikvat.
These reports have been reviewed by the Member States and the Commission within the Standing Committee on the Food Chain and Animal Health and finalised on 20 May 2008 in the format of the Commission review reports for flutolanil, benfluralin, fluazinam, fuberidazole and mepiquat.
Ta poročila so države članice in Komisija pregledale v okviru Stalnega odbora za prehranjevalno verigo in zdravje živali ter 20. maja 2008 pripravile končne različice v obliki poročil Komisije o pregledu za flutolanil, benfluralin, fluazinam, fuberidazol in mepikvat.
It has appeared from the various examinations made that plant protection products containing flutolanil, benfluralin, fluazinam, fuberidazole and mepiquat may be expected to satisfy, in general, the requirements laid down in Article 5(1)(a) and (b) of Directive 91/414/EEC, in particular with regard to the uses which were examined and detailed in the Commission review reports.
Različne preiskave so pokazale, da se za fitofarmacevtska sredstva, ki vsebujejo flutolanil, benfluralin, fluazinam, fuberidazol in mepikvat, lahko pričakuje, da na splošno izpolnjujejo zahteve iz člena 5(1)(a) in (b) Direktive 91/414/EGS, zlasti v zvezi z uporabami, ki so bile proučene in podrobno navedene v poročilih Komisije o pregledu.
Without prejudice to that conclusion, it is appropriate to obtain further information on certain specific points.
Brez poseganja v navedeni sklep je primerno pridobiti nadaljnje informacije o nekaterih posameznih točkah.
Therefore it is appropriate to require that benfluralin should be subject to further testing for confirmation of the risk assessment for consumers and for aquatic organisms and that fluazinam should be subject to further testing for confirmation of the risk assessment for aquatic organisms and soil macro-organisms and such studies should be presented by the notifiers.
Zato je primerno zahtevati, da se izvedejo nadaljnja preskušanja za benfluralin za potrditev ocene tveganja za potrošnike in vodne organizme ter fluazinam za potrditev ocene tveganja za vodne organizme in talne makroorganizme, takšne študije pa morajo predložiti prijavitelji.